Radical Prostatectomy after Vascular Targeted Photodynamic Therapy with Padeliporfin: Feasibility, and Early and Intermediate Results.
Fiche publication
Date publication
février 2019
Journal
The Journal of urology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr KLEINCLAUSS François
Tous les auteurs :
Pierrard V, Lebdai S, Kleinclauss F, Azzouzi AR, Terrier JE, Fortier E, Joniau S, Van Der Poel H, Salomon G, Casanova J, Medina-Lopez RA, Potiron E, Rigaud J, Vincendeau S, Rassweiler J, Villers A, Gaston R, Saussine C, Giai J, Gaillac B, Emberton M, Ruffion A
Lien Pubmed
Résumé
Vascular targeted photodynamic therapy with TOOKAD® is a new therapeutic option for localized prostate cancer management. The objectives of this study were to assess the feasibility of radical prostatectomy after vascular targeted photodynamic therapy and describe functional and oncologic outcomes.
Mots clés
Aged, Bacteriochlorophylls, administration & dosage, Feasibility Studies, Humans, Male, Middle Aged, Neoadjuvant Therapy, methods, Neoplasm Recurrence, Local, epidemiology, Photochemotherapy, methods, Photosensitizing Agents, administration & dosage, Postoperative Complications, epidemiology, Prostate, pathology, Prostatectomy, adverse effects, Prostatic Neoplasms, pathology, Retrospective Studies, Salvage Therapy, adverse effects, Treatment Outcome
Référence
J. Urol.. 2019 02;201(2):315-321